Immuno-Isolating Dual Poly(ethylene glycol) Capsule Prevents Cancer Cells from Spreading Following Mouse Ovarian Tissue Auto-Transplantation

@article{Day2019ImmunoIsolatingDP,
  title={Immuno-Isolating Dual Poly(ethylene glycol) Capsule Prevents Cancer Cells from Spreading Following Mouse Ovarian Tissue Auto-Transplantation},
  author={James Ronald Day and Anu David and Catherine G. Long and Grace G. Bushnell and Teresa K. Woodruff and Lonnie D. Shea and Ariella Shikanov},
  journal={Regenerative medicine frontiers},
  year={2019},
  volume={2019}
}
For female cancer survivors, premature ovarian insufficiency (POI) is a common complication of anticancer treatments. Ovarian tissue cryopreservation before treatment, followed by auto-transplantation after remission is a promising option to restore fertility and ovarian endocrine function. However, auto-transplantation is associated with the risk of re-introducing malignant cells harbored in the stroma of the ovarian autograft. To mitigate this risk, we investigated in this pilot study whether… 
1 Citations

Figures from this paper

Encapsulated allografts preclude host sensitization and promote ovarian endocrine function in ovariectomized young rhesus monkeys and sensitized mice

It is demonstrated, for the first time, that encapsulation of ovarian allografteds prevents sensitization and protects the allograft from rejection in young rhesus monkeys and in sensitized mice.

References

SHOWING 1-10 OF 33 REFERENCES

Restoring Ovarian Endocrine Function with Encapsulated Ovarian Allograft in Immune Competent Mice

Results show that TheraCyte effectively isolates the graft from immune recognition but also supports follicular growth, which was confirmed by decreased serum FSH levels in ovariectomized mice after implantation.

Is transplantation of a few leukemic cells inside an artificial ovary able to induce leukemia in an experimental model?

Transplantation of 100 leukemic cells appears to be insufficient to induce leukemia after 20 weeks, and results in an immunodeficient xenografting model are quite reassuring, however, for clinical application, follicle suspensions must be purged of leukedmic cells before grafting, as even the slightest risk should be avoided.

Is transplantation of cryopreserved ovarian tissue from patients with advanced-stage breast cancer safe? A pilot study

This pilot study is the first to evaluate the risk of contamination of cryopreserved ovarian tissue from advanced-stage breast cancer patients by xenotransplantation for 6 months to immunodeficient mice, associated with more conventional screening methods.

Retrievable hydrogels for ovarian follicle transplantation and oocyte collection

Findings demonstrate a viable option for safe use of potentially cancer‐laden ovarian donor tissue for in vivo follicle maturation within a retrievable hydrogel and subsequent oocyte collection, and may provide novel options to preserve fertility for young female patients with cancer.

Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukemia is potentially unsafe.

By quantitative RT-PCR, ovarian contamination by malignant cells in acute as well as chronic leukemia is demonstrated, whereas histology fails to do so, and chemotherapy before ovarian cryopreservation does not exclude malignant contamination.

Bioengineering the ovarian follicle microenvironment.

This review describes the application of tissue engineering principles to promote ovarian follicle maturation and produce mature oocytes through either in vitro culture or transplantation.

Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients.

Preoperative imaging prevented operations and storage of tissue with cancer and highly sensitive real-time RT-PCR was positive in one CML patient and, this alarming result avoided tissue transplantation.

Ovarian tissue transport to expand access to fertility preservation: from animals to clinical practice.

Empirical evidence from both animal models and human studies suggest that ovarian tissue can be transported at cold temperatures for several hours while still maintaining the integrity and reproductive potential of the primordial follicles within the tissue.